Article Text
DTB select
Safety update on home use of nebulisers for acute asthma treatment in children
Abstract
Overview of: Medicines and Healthcare products Regulatory Agency. Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists. Drug Safety Update 2022;16:1.
- Health Care Quality, Access, and Evaluation
- Drug-Related Side Effects and Adverse Reactions